Literature DB >> 15833814

The gene expression signatures of melanoma progression.

Christopher Haqq1, Mehdi Nosrati, Daniel Sudilovsky, Julia Crothers, Daniel Khodabakhsh, Brian L Pulliam, Scot Federman, James R Miller, Robert E Allen, Mark I Singer, Stanley P L Leong, Britt-Marie Ljung, Richard W Sagebiel, Mohammed Kashani-Sabet.   

Abstract

Because of the paucity of available tissue, little information has previously been available regarding the gene expression profiles of primary melanomas. To understand the molecular basis of melanoma progression, we compared the gene expression profiles of a series of nevi, primary melanomas, and melanoma metastases. We found that metastatic melanomas exhibit two dichotomous patterns of gene expression, which unexpectedly reflect gene expression differences already apparent in comparing laser-capture microdissected radial and vertical phases of a large primary melanoma. Unsupervised hierarchical clustering accurately separated nevi and primary melanomas. Multiclass significance analysis of microarrays comparing normal skin, nevi, primary melanomas, and the two types of metastatic melanoma identified 2,602 transcripts that significantly correlated with sample class. These results suggest that melanoma pathogenesis can be understood as a series of distinct molecular events. The gene expression signatures identified here provide the basis for developing new diagnostics and targeting therapies for patients with malignant melanoma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15833814      PMCID: PMC1087936          DOI: 10.1073/pnas.0501564102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Quantitative analysis of mRNA amplification by in vitro transcription.

Authors:  L R Baugh; A A Hill; E L Brown; C P Hunter
Journal:  Nucleic Acids Res       Date:  2001-03-01       Impact factor: 16.971

2.  Eos and pegasus, two members of the Ikaros family of proteins with distinct DNA binding activities.

Authors:  J Perdomo; M Holmes; B Chong; M Crossley
Journal:  J Biol Chem       Date:  2000-12-08       Impact factor: 5.157

Review 3.  Lymphopoiesis and matrix glycoprotein SC1/ECM2.

Authors:  K Oritani; P W Kincade
Journal:  Leuk Lymphoma       Date:  1998-12

Review 4.  The misdiagnosis of malignant melanoma.

Authors:  J M Grant-Kels; E T Bason; C M Grin
Journal:  J Am Acad Dermatol       Date:  1999-04       Impact factor: 11.527

5.  Molecular classification of cutaneous malignant melanoma by gene expression profiling.

Authors:  M Bittner; P Meltzer; Y Chen; Y Jiang; E Seftor; M Hendrix; M Radmacher; R Simon; Z Yakhini; A Ben-Dor; N Sampas; E Dougherty; E Wang; F Marincola; C Gooden; J Lueders; A Glatfelter; P Pollock; J Carpten; E Gillanders; D Leja; K Dietrich; C Beaudry; M Berens; D Alberts; V Sondak
Journal:  Nature       Date:  2000-08-03       Impact factor: 49.962

6.  Expression of E and P-cadherin by melanoma cells decreases in progressive melanomas and following ultraviolet radiation.

Authors:  P C Seline; D A Norris; T Horikawa; M Fujita; M H Middleton; J G Morelli
Journal:  J Invest Dermatol       Date:  1996-06       Impact factor: 8.551

7.  Use of a cDNA microarray to analyse gene expression patterns in human cancer.

Authors:  J DeRisi; L Penland; P O Brown; M L Bittner; P S Meltzer; M Ray; Y Chen; Y A Su; J M Trent
Journal:  Nat Genet       Date:  1996-12       Impact factor: 38.330

8.  Matrix metalloproteinase expression in malignant melanomas: tumor-extracellular matrix interactions in invasion and metastasis.

Authors:  B Bodey; B Bodey; S E Siegel; H E Kaiser
Journal:  In Vivo       Date:  2001 Jan-Feb       Impact factor: 2.155

9.  Expression profiling using microarrays fabricated by an ink-jet oligonucleotide synthesizer.

Authors:  T R Hughes; M Mao; A R Jones; J Burchard; M J Marton; K W Shannon; S M Lefkowitz; M Ziman; J M Schelter; M R Meyer; S Kobayashi; C Davis; H Dai; Y D He; S B Stephaniants; G Cavet; W L Walker; A West; E Coffey; D D Shoemaker; R Stoughton; A P Blanchard; S H Friend; P S Linsley
Journal:  Nat Biotechnol       Date:  2001-04       Impact factor: 54.908

10.  Cluster analysis and display of genome-wide expression patterns.

Authors:  M B Eisen; P T Spellman; P O Brown; D Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

View more
  164 in total

1.  Nanog and Oct4 overexpression increases motility and transmigration of melanoma cells.

Authors:  Aurelie Borrull; Stephanie Ghislin; Frederique Deshayes; Jessica Lauriol; Catherine Alcaide-Loridan; Sandrine Middendorp
Journal:  J Cancer Res Clin Oncol       Date:  2012-03-11       Impact factor: 4.553

Review 2.  Gene signature of the metastatic potential of cutaneous melanoma: too much for too little?

Authors:  József Tímár; Balázs Gyorffy; Erzsébet Rásó
Journal:  Clin Exp Metastasis       Date:  2010-02-24       Impact factor: 5.150

3.  Genes and pathways downstream of telomerase in melanoma metastasis.

Authors:  Sepideh Bagheri; Mehdi Nosrati; Shang Li; Sylvia Fong; Sima Torabian; Javier Rangel; Dan H Moore; Scot Federman; Rebecca R Laposa; Frederick L Baehner; Richard W Sagebiel; James E Cleaver; Christopher Haqq; Robert J Debs; Elizabeth H Blackburn; Mohammed Kashani-Sabet
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-17       Impact factor: 11.205

4.  Differential regulation of CXC ligand 1 transcription in melanoma cell lines by poly(ADP-ribose) polymerase-1.

Authors:  K I Amiri; H C Ha; M E Smulson; A Richmond
Journal:  Oncogene       Date:  2006-06-26       Impact factor: 9.867

5.  Ribozyme-mediated targeting of IkappaBgamma inhibits melanoma invasion and metastasis.

Authors:  Sima Z Torabian; David de Semir; Mehdi Nosrati; Sepideh Bagheri; Altaf A Dar; Sylvia Fong; Yong Liu; Scot Federman; Jeff Simko; Chris Haqq; Robert J Debs; Mohammed Kashani-Sabet
Journal:  Am J Pathol       Date:  2009-01-29       Impact factor: 4.307

6.  Functional gene expression analysis uncovers phenotypic switch in aggressive uveal melanomas.

Authors:  Michael D Onken; Justis P Ehlers; Lori A Worley; Jun Makita; Yoshifumi Yokota; J William Harbour
Journal:  Cancer Res       Date:  2006-05-01       Impact factor: 12.701

7.  The emerging role of CXCL10 in cancer (Review).

Authors:  Mingli Liu; Shanchun Guo; Jonathan K Stiles
Journal:  Oncol Lett       Date:  2011-05-09       Impact factor: 2.967

8.  Role of p63 in Development, Tumorigenesis and Cancer Progression.

Authors:  Johann Bergholz; Zhi-Xiong Xiao
Journal:  Cancer Microenviron       Date:  2012-07-31

9.  A genome-wide shRNA screen identifies GAS1 as a novel melanoma metastasis suppressor gene.

Authors:  Stephane Gobeil; Xiaochun Zhu; Charles J Doillon; Michael R Green
Journal:  Genes Dev       Date:  2008-11-01       Impact factor: 11.361

Review 10.  Immune-phenotypical markers for the differential diagnosis of melanocytic lesions.

Authors:  Gerardo Botti; Laura Marra; Annamaria Anniciello; Giosuè Scognamiglio; Vincenzo Gigantino; Monica Cantile
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.